CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases

Sézary syndrome (SS) is a rare and aggressive type of cutaneous T-cell lymphoma (CTCL). Due to its rarity and marked biological heterogeneity, SS diagnosis is frequently delayed, as it requires the integration of multiple complex diagnostic tests interpreted by highly specialized biomedical figures....

Descrizione completa

Dettagli Bibliografici

Autori principali:	Giulia Salvatore, Ylenia Aura Minafò, Nicoletta Croce, Francesca Passarelli, Cristina Cristofoletti, Maria Cristina Picchio, Laura Bonmassar, Stefania Madonna, Laura Mercurio, Alessandro Monopoli, Filomena Russo, Gaia Moretta, Enrico Scala, Stefania D’Atri, Maria Grazia Narducci
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-04-01
Serie:	Frontiers in Immunology
Soggetti:	cutaneous T-cell lymphoma CXCL13 differential diagnostic marker ELISA IHC RT-qPCR
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1804103/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!